Vascular Medial Hyperplasia Following Chronic, Intermittent Exposure to 4,4′-Methylenedianiline

Tammy R. Dugas, Mary F. Kanz, Valeria Y. Hebert, Kendall L. Hennard, Hanlin Liu, Vicente Santa Cruz, Daniel Conklin, Paul J. Boor

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

4,4′-Methylenedianiline (DAPM) is an aromatic amine used in the synthesis of polyurethanes and epoxy resins. Acute exposure to DAPM produces hepatobiliary toxicity in humans as well as animal models. However, the toxic effects of intermittent DAPM exposure have not been explored. We treated male and female rats with 25 mg DAPM/kg or vehicle once per week for 17-22 wk. Though concentric fibrosis around bile ducts of the liver was noted, vascular medial hyperplasia was also prominent. Morphometric analysis of histologic sections revealed that in male rats, vessel wall area increased relative to lumen area in hepatic arteries by 22 wk. However, in female rats, wall areas of both hepatic and pulmonary arteries increased relative to lumen area by 17 wk. In both male and female rats, increased wall thickness was localized to the medial layer; no intimal changes were noted. In vitro treatment of vascular smooth muscle cells (VSMC) with 25-100 μM DAPM resulted in increased DNA synthesis and VSMC proliferation. To test whether the observed alterations in cell cycle control involved VSMC-mediated metabolism of DAPM to electrophilic intermediates, cells were treated with DAPM or DAPM plus 50 μM N-acetylcysteine (NAC). Coincubation with NAC afforded dramatic protection against DAPM-induced VSMC proliferation. Though DAPM had no appreciable effect on levels of reduced glutathione, oxidized glutathione, or oxidant production, DAPM increased glutathione-S-transferase activity in VSMC. These data indicate that DAPM can initiate VSMC proliferation, possibly via VSMC-mediated metabolism of DAPM to reactive intermediates.

Original languageEnglish (US)
Pages (from-to)85-95
Number of pages11
JournalCardiovascular Toxicology
Volume4
Issue number1
DOIs
StatePublished - 2004

Fingerprint

Hyperplasia
Blood Vessels
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Rats
Cell proliferation
Hepatic Artery
Cell Proliferation
Acetylcysteine
Metabolism
DAPM
Cells
Tunica Intima
Epoxy Resins
Polyurethanes
Glutathione Disulfide
Poisons
Cell Cycle Checkpoints
Bile Ducts

Keywords

  • Glutathione
  • Glutathione-S-transferase
  • Methylenedianiline
  • Proliferation
  • Vascular smooth muscle cells

ASJC Scopus subject areas

  • Toxicology
  • Cardiology and Cardiovascular Medicine

Cite this

Dugas, T. R., Kanz, M. F., Hebert, V. Y., Hennard, K. L., Liu, H., Santa Cruz, V., ... Boor, P. J. (2004). Vascular Medial Hyperplasia Following Chronic, Intermittent Exposure to 4,4′-Methylenedianiline. Cardiovascular Toxicology, 4(1), 85-95. https://doi.org/10.1385/CT:4:1:85

Vascular Medial Hyperplasia Following Chronic, Intermittent Exposure to 4,4′-Methylenedianiline. / Dugas, Tammy R.; Kanz, Mary F.; Hebert, Valeria Y.; Hennard, Kendall L.; Liu, Hanlin; Santa Cruz, Vicente; Conklin, Daniel; Boor, Paul J.

In: Cardiovascular Toxicology, Vol. 4, No. 1, 2004, p. 85-95.

Research output: Contribution to journalArticle

Dugas, TR, Kanz, MF, Hebert, VY, Hennard, KL, Liu, H, Santa Cruz, V, Conklin, D & Boor, PJ 2004, 'Vascular Medial Hyperplasia Following Chronic, Intermittent Exposure to 4,4′-Methylenedianiline', Cardiovascular Toxicology, vol. 4, no. 1, pp. 85-95. https://doi.org/10.1385/CT:4:1:85
Dugas, Tammy R. ; Kanz, Mary F. ; Hebert, Valeria Y. ; Hennard, Kendall L. ; Liu, Hanlin ; Santa Cruz, Vicente ; Conklin, Daniel ; Boor, Paul J. / Vascular Medial Hyperplasia Following Chronic, Intermittent Exposure to 4,4′-Methylenedianiline. In: Cardiovascular Toxicology. 2004 ; Vol. 4, No. 1. pp. 85-95.
@article{f83b1d4c3953465381218bd5ac1f562a,
title = "Vascular Medial Hyperplasia Following Chronic, Intermittent Exposure to 4,4′-Methylenedianiline",
abstract = "4,4′-Methylenedianiline (DAPM) is an aromatic amine used in the synthesis of polyurethanes and epoxy resins. Acute exposure to DAPM produces hepatobiliary toxicity in humans as well as animal models. However, the toxic effects of intermittent DAPM exposure have not been explored. We treated male and female rats with 25 mg DAPM/kg or vehicle once per week for 17-22 wk. Though concentric fibrosis around bile ducts of the liver was noted, vascular medial hyperplasia was also prominent. Morphometric analysis of histologic sections revealed that in male rats, vessel wall area increased relative to lumen area in hepatic arteries by 22 wk. However, in female rats, wall areas of both hepatic and pulmonary arteries increased relative to lumen area by 17 wk. In both male and female rats, increased wall thickness was localized to the medial layer; no intimal changes were noted. In vitro treatment of vascular smooth muscle cells (VSMC) with 25-100 μM DAPM resulted in increased DNA synthesis and VSMC proliferation. To test whether the observed alterations in cell cycle control involved VSMC-mediated metabolism of DAPM to electrophilic intermediates, cells were treated with DAPM or DAPM plus 50 μM N-acetylcysteine (NAC). Coincubation with NAC afforded dramatic protection against DAPM-induced VSMC proliferation. Though DAPM had no appreciable effect on levels of reduced glutathione, oxidized glutathione, or oxidant production, DAPM increased glutathione-S-transferase activity in VSMC. These data indicate that DAPM can initiate VSMC proliferation, possibly via VSMC-mediated metabolism of DAPM to reactive intermediates.",
keywords = "Glutathione, Glutathione-S-transferase, Methylenedianiline, Proliferation, Vascular smooth muscle cells",
author = "Dugas, {Tammy R.} and Kanz, {Mary F.} and Hebert, {Valeria Y.} and Hennard, {Kendall L.} and Hanlin Liu and {Santa Cruz}, Vicente and Daniel Conklin and Boor, {Paul J.}",
year = "2004",
doi = "10.1385/CT:4:1:85",
language = "English (US)",
volume = "4",
pages = "85--95",
journal = "Cardiovascular Toxicology",
issn = "1530-7905",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Vascular Medial Hyperplasia Following Chronic, Intermittent Exposure to 4,4′-Methylenedianiline

AU - Dugas, Tammy R.

AU - Kanz, Mary F.

AU - Hebert, Valeria Y.

AU - Hennard, Kendall L.

AU - Liu, Hanlin

AU - Santa Cruz, Vicente

AU - Conklin, Daniel

AU - Boor, Paul J.

PY - 2004

Y1 - 2004

N2 - 4,4′-Methylenedianiline (DAPM) is an aromatic amine used in the synthesis of polyurethanes and epoxy resins. Acute exposure to DAPM produces hepatobiliary toxicity in humans as well as animal models. However, the toxic effects of intermittent DAPM exposure have not been explored. We treated male and female rats with 25 mg DAPM/kg or vehicle once per week for 17-22 wk. Though concentric fibrosis around bile ducts of the liver was noted, vascular medial hyperplasia was also prominent. Morphometric analysis of histologic sections revealed that in male rats, vessel wall area increased relative to lumen area in hepatic arteries by 22 wk. However, in female rats, wall areas of both hepatic and pulmonary arteries increased relative to lumen area by 17 wk. In both male and female rats, increased wall thickness was localized to the medial layer; no intimal changes were noted. In vitro treatment of vascular smooth muscle cells (VSMC) with 25-100 μM DAPM resulted in increased DNA synthesis and VSMC proliferation. To test whether the observed alterations in cell cycle control involved VSMC-mediated metabolism of DAPM to electrophilic intermediates, cells were treated with DAPM or DAPM plus 50 μM N-acetylcysteine (NAC). Coincubation with NAC afforded dramatic protection against DAPM-induced VSMC proliferation. Though DAPM had no appreciable effect on levels of reduced glutathione, oxidized glutathione, or oxidant production, DAPM increased glutathione-S-transferase activity in VSMC. These data indicate that DAPM can initiate VSMC proliferation, possibly via VSMC-mediated metabolism of DAPM to reactive intermediates.

AB - 4,4′-Methylenedianiline (DAPM) is an aromatic amine used in the synthesis of polyurethanes and epoxy resins. Acute exposure to DAPM produces hepatobiliary toxicity in humans as well as animal models. However, the toxic effects of intermittent DAPM exposure have not been explored. We treated male and female rats with 25 mg DAPM/kg or vehicle once per week for 17-22 wk. Though concentric fibrosis around bile ducts of the liver was noted, vascular medial hyperplasia was also prominent. Morphometric analysis of histologic sections revealed that in male rats, vessel wall area increased relative to lumen area in hepatic arteries by 22 wk. However, in female rats, wall areas of both hepatic and pulmonary arteries increased relative to lumen area by 17 wk. In both male and female rats, increased wall thickness was localized to the medial layer; no intimal changes were noted. In vitro treatment of vascular smooth muscle cells (VSMC) with 25-100 μM DAPM resulted in increased DNA synthesis and VSMC proliferation. To test whether the observed alterations in cell cycle control involved VSMC-mediated metabolism of DAPM to electrophilic intermediates, cells were treated with DAPM or DAPM plus 50 μM N-acetylcysteine (NAC). Coincubation with NAC afforded dramatic protection against DAPM-induced VSMC proliferation. Though DAPM had no appreciable effect on levels of reduced glutathione, oxidized glutathione, or oxidant production, DAPM increased glutathione-S-transferase activity in VSMC. These data indicate that DAPM can initiate VSMC proliferation, possibly via VSMC-mediated metabolism of DAPM to reactive intermediates.

KW - Glutathione

KW - Glutathione-S-transferase

KW - Methylenedianiline

KW - Proliferation

KW - Vascular smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=1942518411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942518411&partnerID=8YFLogxK

U2 - 10.1385/CT:4:1:85

DO - 10.1385/CT:4:1:85

M3 - Article

C2 - 15034207

AN - SCOPUS:1942518411

VL - 4

SP - 85

EP - 95

JO - Cardiovascular Toxicology

JF - Cardiovascular Toxicology

SN - 1530-7905

IS - 1

ER -